Dou, Yali

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature

Cancer Immunotherapy and BiomarkersEpigenetics and DNA Methylation

Cited by 1,201

Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer

Bai, L., Zhou, B., Yang, C.-Y., Ji, J., McEachern, D., Przybranowski, S., Jiang, H., Hu, J., Xu, F., Zhao, Y., et al. (2017) · Cancer Research

Protein Degradation and InhibitorsHistone Deacetylase Inhibitors Research

Cited by 199

HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis

Sun, Y., Zhou, B., Mao, F., Xu, J., Miao, H., Zou, Z., Phuc Khoa, L. T., Jang, Y., Cai, S., Witkin, M., et al. (2018) · Cancer Cell

Acute Myeloid Leukemia ResearchGenomics and Chromatin Dynamics

Cited by 152

KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway

Yi, Z., Wei, S., Jin, L., Jeyarajan, S., Yang, J., Gu, Y., Kim, H. S., Schechter, S., Lu, S., Paulsen, M. T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology

Pancreatic and Hepatic Oncology ResearchEpigenetics and DNA Methylation

Cited by 41

Histone methyltransferase KMT2A: developmental regulation to oncogenic transformation

Ogino, J., & Dou, Y. (2024) · Journal of Biological Chemistry

Epigenetics and DNA MethylationChromatin Remodeling and Cancer

Cited by 21